-
Increased fetal nuchal translucency thickness at 10-14 weeks: is screening for maternal-fetal infection necessary?
Sebire NJ, Bianco D, Snijders RJM, Zuckerman M, Nicolaides KH.
BJOG 1997;104:212-5. -
Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome.
Sebire NJ, D'Ercole C, Hughes K, Carvalho M, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;10:86-9. -
Down's syndrome screening with nuchal translucency.
Nicolaides KH, Sebire NJ, Snijders RJ.
Lancet 1997;349:438. -
Early prenatal diagnosis of triploidy.
Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH.
Am J Obstet Gynecol 1997;176:550-4. -
Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation.
Hyett JH, Noble P, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;9:310-3. -
Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
Hyett JA, Perdu M, Sharland GK, Snijders RSM, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;10:242-6. -
Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses.
Hyett J, Moscoso G, Nicolaides KH.
Am J Med Genet 1997;69:207-16. -
First-trimester ultrasound screening for chromosomal defects.
Snijders RJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:216-26. -
Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH.
BJOG 1996;103:999-1003. -
Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency.
Sebire NJ, Noble PL, Psarra A, Papapanagiotou G, Nicolaides KH.
BJOG 1996;103:887-90. -
Down's syndrome screeening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S, Reynolds TM.
Lancet 1996;347:906-7. -
Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness.
Jauniaux E, Gavrill P, Kuhn P, Kurdi W, Hyett J, Nicolaides KH.
Hum Reprod 1996;11:435-9. -
Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency.
Hyett JH, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:101-3. -
Abnormatlities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation.
Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:245-50.